Anal melanoma in Colombia: A retrospective cohort survival study from an institutional melanoma registry

Autores/as

DOI:

https://doi.org/10.30944/20117582.3224

Palabras clave:

anal neoplasms, melanoma, survival analysis, treatment, Colombia

Resumen

Introduction. Anal melanoma (AM) is an uncommon and aggressive mucosal melanoma subtype with a poor prognosis. Evidence from Latin America is scarce, and no Colombian study has characterized survival or treatment patterns in AM.

Methods. We performed a retrospective cohort analysis using a national institutional melanoma registry (2010– 2021). From 766 melanoma cases, all patients with histologically confirmed anal or anorectal primary melanoma (ICD-10 C21.x) were included. Clinical, pathological, treatment, and survival data were extracted from electronic medical records. Overall survival (OS) was estimated using Kaplan–Meier analysis.

Results. Seven patients (0.9%) had AM. The median age at diagnosis was 61 years; 71.4% were female, most belonged to low socioeconomic strata. Diagnostic delay was frequent: median symptom-to-diagnosis interval was 7 months. At presentation, 71.4% had distant metastases; ulceration was present in 85.7%. Treatments included wide/local excision (42.8%), abdominoperineal resection (28.6%), radiotherapy (57.1%), and systemic therapy (71.4%), including immune checkpoint inhibitors. Toxicities led to treatment discontinuation in some cases. Median OS: 9.4 months; patients diagnosed with metastatic disease had an OS of 4.2 months. Six patients died despite multimodal therapy. The only 5-year survivor was diagnosed incidentally at an early stage.

Conclusion. Anal melanoma in Colombia is rare but almost uniformly fatal. Delayed diagnosis—due to nonspecific anorectal symptoms and limited access to specialist evaluation—was the dominant driver of poor survival. Early detection, particularly in patients with a personal history of melanoma, is crucial. Prompt anorectal examination and biopsy of persistent symptoms may offer the only opportunity to alter prognosis.

Descargas

Los datos de descargas todavía no están disponibles.

Referencias bibliográficas

Huang H, Chen L, Chen T, Sun G. Rectal malignant melanoma: a case report and literature review. World J Surg Oncol. 2025;23:17. https://doi.org/10.1186/s1295702503632-8

García AM, ParraLara LG, MendozaUrbano DM, Bravo JC, Zambrano Harvey Á. Survival of patients with mucosal melanoma in Cali, Colombia: a retrospective cohort study. BMC Cancer. 2024;24:886. https://doi.org/10.1186/s12885024131707

Jutten E, Kruijff S, Francken AB, Lutke Holzik MF, van Leeuwen BL, van Westreenen HL, et al. Surgical treatment of anorectal melanoma: a systematic review. Updates Surg. 2021;73:1407-17. https://doi.org/10.1093/bjsopen/zrab107

Shan Z, Liu F. Advances in immunotherapy for mucosal melanoma: harnessing immune checkpoint inhibitors for improved treatment outcomes. Front Immunol. 2024;15:1441410. https://doi.org/10.3389/fimmu.2024.1441410

Arias Flórez M, Moreno Gómez GA, Aguirre Flórez M, López Bueno I, Moreno Gómez J, Moreno Gómez M, et al. Melanoma in a Colombian population: a survival study. Melanoma Manag. 2024;11:2382079. https://doi.org/10.2217/mmt20240003

Paolino G, Podo Brunetti A, De Rosa C, Cantisani C, Rongioletti F, Carugno A, et al. Anorectal melanoma: systematic review of the current literature. Dermatol Ther (Heidelb). 2024;14:1667-84. https://doi.org/10.1007/s13555024010791

Chen H, Cai Y, Liu Y, He J, Hu Y, Xiao Q, et al. Incidence, surgical treatment, and prognosis of anorectal melanoma. Medicine (Baltimore). 2016;95:e2770. https://doi.org/10.1097/MD.0000000000002770

Liu C, Tang C, Zhang J, Zhu P. Extensive resection improves overall and disease-specific survival compared with local excision in localized anorectal melanoma: a SEER-based analysis. Front Surg. 2022;9:997169. https://doi.org/10.3389/fsurg.2022.997169

Ortega A, GarcíaMarín A, Alós R, et al. Melanoma anorrectal: actualización. Cir Esp. 2015;93:e73e82. https://doi.org/10.1016/j.ciresp.2015.04.009

Biswas J, Matthews S, Gopal L, et al. Challenges in managing anorectal melanoma. Clin Imaging. 2023;92:73-82. https://doi.org/10.1016/j.clinimag.2022.11.020

Ghiasvand R, Robsahm TE, Green AC, Veierød MB. Incidence and factors associated with second primary invasive melanoma. JAMA Dermatol. 2024;160:402-8. https://doi.org/10.1001/jamadermatol.2023.6251

Du Y, Wang X, Mao X, Cai B, Peng J, Li H, et al. Immunotherapy for mucosal melanoma. Oncol Transl Med. 2023;9:179-88. https://doi.org/10.1097/OT9.0000000000000019

ASCO Daily News. Management of anorectal melanoma in an era of immunotherapy. ASCO Daily News. Jan 6, 2021. Available from: https://dailynews.ascopubs.org/do/management-anorectal-melanoma-era-immunotherapy.

Wallington DG, Fernandez J, Perkins S, et al. Complete and durable response after radiation therapy combined with checkpoint blockade in mucosal melanoma. Adv Radiat Oncol. 2020;5:1174-9. https://doi.org/10.1016/j.adro.2020.08.002

Marulanda Fernández H, Velásquez D, RíosBermúdez A, GarcíaMoreno M, Cadena M, Restrepo CC, et al. Primary anorectal melanoma: case report and literature review. Rev Col Gastroenterol. 2023;38:e1357. https://doi.org/10.22516/25007440.1357

NiY, Chen S, Wang S, LiP, ZhangY, HuangX, et al. Absolute risk of developing a second primary cancer after a first melanoma. Am J Epidemiol. 2025;kwaf068. https://doi.org/10.1093/aje/kwaf068

Antoñanzas J, García-Fernández S, MartínezCuadrado G, Pérez-Gómez B, Sánchez-Sánchez R, LópezLópez J, et al. Risk of second primary malignancies in melanoma survivors: a populationbased study. Cancers (Basel). 2023;15:3056. https://doi.org/10.3390/cancers15113056

Edelman A, Brown T, Gandhi R, Gandhi R. Anorectal melanoma misdiagnosed as hemorrhoids: a case report. Cureus. 2021;13:e15055. https://doi.org/10.7759/cureus.15055

Descargas

Publicado

2026-09-29

Cómo citar

(1)
Milián-Berrío, M. M.; Arias-Flórez, M.; Aguirre-Flórez, M.; Gómez-González, J. F.; Moreno-Gómez, G. A.; Figueroa-Avendaño, C. E. Anal Melanoma in Colombia: A Retrospective Cohort Survival Study from an Institutional Melanoma Registry. Rev Colomb Cir 2026, 41, 1132-1141.

Número

Sección

Artículo Original

Métricas

Escanea para compartir
QR Code
Crossref Cited-by logo
Estadísticas de artículo
Vistas de resúmenes310
Vistas de PDF99
Descargas de PDF99
Vistas de HTML0
Otras vistas0

Algunos artículos similares: